<bill session="107" type="h" number="1504" updated="2013-07-14T18:57:34-04:00">
  <state datetime="2001-04-04">REFERRED</state>
  <status>
    <introduced datetime="2001-04-04"/>
  </status>
  <introduced datetime="2001-04-04"/>
  <titles>
    <title as="introduced" type="short">Vaccines for the New Millennium Act of 2001</title>
    <title as="introduced" type="official">To amend the Internal Revenue Code of 1986 to allow a credit against income tax for research related to developing vaccines against widespread diseases and ensure that such vaccines are affordable and widely distributed.</title>
  </titles>
  <sponsor id="400314"/>
  <cosponsors>
    <cosponsor id="400527" joined="2001-10-31"/>
    <cosponsor id="400073" joined="2001-04-04"/>
    <cosponsor id="400103" joined="2001-04-04"/>
    <cosponsor id="400106" joined="2001-04-04"/>
    <cosponsor id="400117" joined="2001-04-04"/>
    <cosponsor id="400123" joined="2001-04-04"/>
    <cosponsor id="400133" joined="2001-04-04"/>
    <cosponsor id="400136" joined="2001-04-04"/>
    <cosponsor id="400143" joined="2001-05-17"/>
    <cosponsor id="400201" joined="2001-04-04"/>
    <cosponsor id="400222" joined="2001-05-17"/>
    <cosponsor id="400231" joined="2001-04-04"/>
    <cosponsor id="400240" joined="2001-04-04"/>
    <cosponsor id="400262" joined="2001-04-04"/>
    <cosponsor id="400268" joined="2001-04-04"/>
    <cosponsor id="400275" joined="2001-04-04"/>
    <cosponsor id="400524" joined="2001-04-04"/>
    <cosponsor id="400333" joined="2001-04-04"/>
    <cosponsor id="400347" joined="2001-04-04"/>
    <cosponsor id="400366" joined="2001-04-04"/>
    <cosponsor id="400396" joined="2001-05-17"/>
    <cosponsor id="400509" joined="2001-04-04"/>
    <cosponsor id="400409" joined="2001-04-04"/>
    <cosponsor id="400436" joined="2001-04-04"/>
    <cosponsor id="400438" joined="2001-04-04"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2001-04-04">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and International Relations, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2001-04-04">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2001-04-04">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2001-04-04">
      <text>Referred to House International Relations</text>
    </action>
    <action datetime="2001-04-05">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E554"/>
    </action>
    <action datetime="2001-04-25">
      <text>Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.</text>
      <committee name="House Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSFA" name="House International Relations" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
    <term name="AIDS (Disease)"/>
    <term name="Biotechnology"/>
    <term name="Business income tax"/>
    <term name="Clinical trials"/>
    <term name="Commerce"/>
    <term name="Communicable diseases"/>
    <term name="Developing countries"/>
    <term name="Drug industry"/>
    <term name="Economics and public finance"/>
    <term name="Government trust funds"/>
    <term name="Health"/>
    <term name="Human immunodeficiency viruses"/>
    <term name="Income tax"/>
    <term name="International affairs"/>
    <term name="International agencies"/>
    <term name="International cooperation"/>
    <term name="Malaria"/>
    <term name="Medical research"/>
    <term name="Microbiological research"/>
    <term name="Nonprofit organizations"/>
    <term name="Pharmaceutical research"/>
    <term name="Research and development tax credit"/>
    <term name="Science, technology, communications"/>
    <term name="Social welfare"/>
    <term name="Tuberculosis"/>
    <term name="Vaccines"/>
    <term name="World health"/>
  </subjects>
  <amendments/>
  <summary>4/4/2001--Introduced.
Vaccines for the New Millennium Act of 2001 - Amends the Internal Revenue Code to allow a limited business credit for the costs medical research related to developing vaccines against widespread diseases. Defines widespread diseases as malaria, tuberculosis, HIV, or any infectious disease (of a single etiology) which, according to the World Health Organization, causes over one million human deaths annually.Allows a limited lifesaving vaccine sale credit equal to the amount of qualified vaccine sales. Defines qualified vaccine sales as the aggregate amount paid to the taxpayer for a qualified sale. Defines a qualified sale as a sale of a qualified vaccine: (1) to a nonprofit organization or to a government of any foreign country (or instrumentality of such a government); and (2) for distribution in a developing country.Establishes the Lifesaving Vaccine Purchase Fund.Expresses the sense of Congress concerning the manufacture, distribution, support for global efforts, and tiered pricing of vaccines.</summary>
</bill>
